Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | CHIT1 | Q13231 | 2/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | CA4 | P22748 | 4/20 | 0.35 |
| ▸ | CA9 | Q16790 | 4/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1996255 | 1.00 | FOLH1 (0.45) | FOLH1CHIT1DPP4S1PR1DPP7 | |
| SCHEMBL1079200 | 1.00 | FOLH1 (0.45) | FOLH1CHIT1DPP4S1PR1DPP7 | |
| SCHEMBL15904929 | 1.00 | FOLH1 (0.45) | FOLH1CHIT1DPP4S1PR1DPP7 | |
| SCHEMBL17119211 | 1.00 | FOLH1 (0.45) | FOLH1CHIT1DPP4S1PR1DPP7 | |
| Hydrochloric Acid SCHEMBL31226505 | 0.99 | FOLH1 (0.44) | FOLH1CHIT1DPP4S1PR1DPP7 | |
| SCHEMBL436094 | 0.94 | LMNA (0.45) | FOLH1CHIT1DPP4S1PR1CA1 | |
| SCHEMBL23627788 | 0.93 | HSD17B10 (0.44) | FOLH1CHIT1DPP4 | |
| SCHEMBL12974377 | 0.93 | FOLH1 (0.41) | FOLH1CHIT1DPP4SIGMAR1 | |
| SCHEMBL4098689 | 0.93 | HSD17B10 (0.44) | FOLH1CHIT1DPP4 | |
| SCHEMBL12261650 | 0.93 | FOLH1 (0.41) | FOLH1CHIT1DPP4S1PR1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7132513-B2 | Bifunctional chelating agent | EUROPEAN COMMUNITY (BE) | 2006-11-07 | — | — | US | disclosed |
| US-6696551-B1 | RADIOIMMUNOTHERAPY, DECONTAMINATION AND DETOXIFICATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-02-24 | — | — | US | disclosed |
| US-20030027302-A1 | Bifunctional chelating agent | INSERM INSTITUT NATIOANL DE LA SANTE ET DE LA REOHERCHE MEDICALE (FR) | 2003-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030027302-A1 | Bifunctional chelating agent | H1-2, H1-0, H1-5 | FOLH1 497/4885CHIT1 1613/4885DPP4 3126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.